BSX vs EW — Key Metrics

Metric BSX (BOSTON SCIENTIFIC CORP) EW (EDWARDS LIFESCIENCES CORP)
Price43.64105.23
Market Cap63.26 Billion60.51 Billion
P/E (TTM)18.3459.45
P/B (Quarterly)2.5065.261
P/S (TTM)3.09.07
Net Profit Margin (TTM)16.615.3
Gross Margin (TTM)69.178.0
ROE (TTM)13.99.7
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

BOSTON SCIENTIFIC CORP
vs
 
EDWARDS LIFESCIENCES CORP
 
BOSTON SCIENTIFIC CORP
vs
 
EDWARDS LIFESCIENCES CORP
Performance Comparison
AI Model Recommendation
BSX · BOSTON SCIENTIFIC CORP

Greatly Outperform

84
UnderperformOutperform
EW · EDWARDS LIFESCIENCES CORP
hmmm...
Recommendation Summary

Stock BSX is projected to greatly outperform the market, stock EW is projected to underperform the market. Upfront Recommendation: BSX.

Financial Metrics
Prices delayed ~15 min
BSX Metrics EW
$43.64 Price $105.23
— Market Capitalization —
18.34 Price to Earnings Ratio 59.45
3.0 Price to Sales 9.07
18.99 Price to FCF Ratio 42.49
4.34 Price to Gross Profit 11.62
29.3 Price to R&D 55.45
7.75 Price to Current Assets 8.35

BSX vs EW at a glance

Boston Scientific Corp (BSX) and Edwards Lifesciences Corp (EW) are both Medical Devices companies in the Healthcare sector. They are similar in size: $63.3 billion and $60.5 billion in market value.

On trailing-twelve-month figures, BSX trades at 18.3 times trailing earnings and EW at 59.5; net profit margins are 16.6% and 15.3%.

The Upfront Investment model currently rates BSX Greatly Outperform and EW Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.